Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Saved in:
| Title: | Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia. |
|---|---|
| Authors: | Lin WY; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Fordham SE; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Hungate E; Section of Pediatric Hematology and Oncology, University of Chicago, Chicago, IL, USA., Sunter NJ; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Elstob C; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Xu Y; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Park C; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Quante A; Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Ludwig-Maximilians-Universität München, Chair of Genetic Epidemiology, IBE, Faculty of Medicine, Munich, Germany., Strauch K; Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Ludwig-Maximilians-Universität München, Chair of Genetic Epidemiology, IBE, Faculty of Medicine, Munich, Germany., Gieger C; Ludwig-Maximilians-Universität München, Chair of Genetic Epidemiology, IBE, Faculty of Medicine, Munich, Germany., Skol A; Section of Pediatric Hematology and Oncology, University of Chicago, Chicago, IL, USA., Rahman T; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Sucheston-Campbell L; College of Pharmacy, The Ohio State University, Columbus, OH, USA., Wang J; College of Pharmacy, The Ohio State University, Columbus, OH, USA., Hahn T; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Clay-Gilmour AI; Arnold School of Public Health, Department of Epidemiology & Biostatistics, University of South Carolina, Greenville, SC, USA., Jones GL; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK., Marr HJ; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK., Jackson GH; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK., Menne T; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK., Collin M; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK., Ivey A; Department of Medical and Molecular Genetics, King's College Medical School, London, UK., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Burnett AK; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, UK., Russell NH; Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Fitzgibbon J; Barts Cancer Institute, Queen Mary University of London, London, UK., Larson RA; Section of Pediatric Hematology and Oncology, University of Chicago, Chicago, IL, USA., Le Beau MM; Section of Pediatric Hematology and Oncology, University of Chicago, Chicago, IL, USA., Stock W; Section of Pediatric Hematology and Oncology, University of Chicago, Chicago, IL, USA., Heidenreich O; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Alharbi A; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Allsup DJ; Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Norden J; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Dickinson AM; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Douglas E; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Lendrem C; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Daly AK; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Palm L; West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK., Piechocki K; West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK., Jeffries S; West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK., Bornhäuser M; Department of Haematological Medicine, The Rayne Institute, King's College London, London, UK.; National Center for Tumor Diseases NCT, Partner site Dresden, Dresden, Germany.; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany., Röllig C; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany., Altmann H; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany., Ruhnke L; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany., Kunadt D; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany., Wagenführ L; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany., Cordell HJ; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Darlay R; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Andersen MK; Department of Clinical Genetics, University Hospital Rigshospitalet, Copenhagen, Denmark., Fontana MC; Institute of Hematology 'L. and A. Seràgnoli', University of Bologna, Bologna, Italy.; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Martinelli G; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Marconi G; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Sanz MA; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Cervera J; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Gómez-Seguí I; Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Cluzeau T; Hematology department, Cote d'Azur University, CHU of Nice, Nice, France., Moreilhon C; Hematology department, Cote d'Azur University, CHU of Nice, Nice, France., Raynaud S; Hematology department, Cote d'Azur University, CHU of Nice, Nice, France., Sill H; Division of Hematology, Medical University of Graz, Graz, Austria., Voso MT; Università di Roma Tor Vergata, Dipartimento di Biomedicina e Prevenzione, Rome, Italy., Lo-Coco F; Università di Roma Tor Vergata, Dipartimento di Biomedicina e Prevenzione, Rome, Italy., Dombret H; Hôpital Saint-Louis, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France., Cheok M; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000, Lille, France., Preudhomme C; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000, Lille, France., Gale RE; Department of Haematology, University College London Cancer Institute, London, UK., Linch D; Department of Haematology, University College London Cancer Institute, London, UK., Gaal-Wesinger J; 1st Department of Internal Medicine, Semmewleis University, Budapest, Hungary., Masszi A; 3rd Department of Internal Medicine, Semmewleis University, Budapest, Hungary., Nowak D; Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Hofmann WK; Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Gilkes A; Department of Haematology, University of Cardiff, Cardiff, UK., Porkka K; Helsinki University Hospital Comprehensive Cancer Center, Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland., Milosevic Feenstra JD; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Grimwade D; Department of Medical and Molecular Genetics, King's College Medical School, London, UK., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Krizsán S; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Bödör C; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Stölzel F; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany. friedrich.stoelzel@uniklinikum-dresden.de., Onel K; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. kenan.onel@mssm.edu., Allan JM; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. james.allan@newcastle.ac.uk. |
| Source: | Nature communications [Nat Commun] 2022 Jan 04; Vol. 13 (1), pp. 2. Date of Electronic Publication: 2022 Jan 04. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-021-27679-6 |
